Drug Shortage Report for FLOVENT HFA
| Report ID | 176932 |
| Drug Identification Number | 02244293 |
| Brand name | FLOVENT HFA |
| Common or Proper name | fluticasone propionate inhalation aerosol |
| Company Name | GLAXOSMITHKLINE INC |
| Market Status | MARKETED |
| Active Ingredient(s) | FLUTICASONE PROPIONATE |
| Strength(s) | 250MCG |
| Dosage form(s) | METERED-DOSE AEROSOL |
| Route of administration | ORAL INHALATION ORAL INHALATION |
| Packaging size | 1x120 |
| ATC code | R03BA |
| ATC description | OTHER DRUGS FOR OBSTRUCTIVE AIRWAY DISEASES, INHALANTS |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | |
| Actual start date | 2022-11-29 |
| Estimated end date | 2023-01-31 |
| Actual end date | 2023-02-01 |
| Shortage status | Resolved |
| Updated date | 2023-02-02 |
| Company comments | |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | 1-800-387-7374 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v7 | 2023-02-02 | English | Compare |
| v6 | 2023-02-01 | French | Compare |
| v5 | 2023-02-01 | English | Compare |
| v4 | 2022-12-14 | French | Compare |
| v3 | 2022-12-14 | English | Compare |
| v2 | 2022-12-02 | French | Compare |
| v1 | 2022-12-02 | English | Compare |
Showing 1 to 7 of 7